Health Care: Drugs

PDL BioPharma Inc (PDLI: NASDAQ)

$2.105 0.045 | 2.18%
12/06/16 - 11:21 AM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 554.25M 533.21M 437.28M 374.52M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 554.25M 533.21M 437.28M 374.52M
Selling, General, and Administrative Expenses 36.09M 34.91M 29.75M 25.47M
Research & Development 0.00 0.00 0.00 0.00
Operating Income before D & A (EBITDA) 518.16M 498.29M 407.53M 349.06M
Depreciation & Amortization 13.00M 18.83M 13.72M 14.65M
Interest Income 368.00K 315.00K 242.00K 6.36M
Other Income - Net 38.67M 41.88M 18.98M 758.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 544.19M 521.65M 413.02M 341.52M
Interest Expense 27.06M 39.21M 24.87M 29.04M
Pre-Tax Income 517.13M 482.44M 388.15M 312.48M
Income Taxes 197.34M 179.03M 137.35M 115.46M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 332.80M 322.24M 264.53M 211.67M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 332.80M 322.24M 264.53M 211.67M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 332.80M 322.24M 264.53M 211.67M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
332.80M 322.24M 264.53M 211.67M
Preferred Dividends
Net Income Available To Common 332.80M 322.24M 264.53M 211.67M
Basic EPS from Continuing Ops. 2.04 2.04 1.89 1.52
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.04 2.04 1.89 1.52
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.04 2.04 1.89 1.52
Basic Normalized Net Income/Share 2.04 2.04 1.89 1.52
EPS fr Continuing Ops. 2.03 1.86 1.66 1.45
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.03 1.86 1.66 1.45
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.03 1.86 1.66 1.45
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.03 1.86 1.66 1.45
Dividends Paid per Share 0.60 0.60 0.60 0.60

Portfolios with PDLI

Latest PDLI Headlines from TheStreet

More Financial News for PDLI

Press Releases for PDLI

See All Press Releases

Partner Headlines for PDLI

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter